GLIOBLASTOMA RESEARCH ORGANIZATION INC (EIN 832388861) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

AMBER BARBACH

Phone

3059848164

Tax Period

2024-01-01 to 2024-12-31

GLIOBLASTOMA RESEARCH ORGANIZATION INC, founded in 2018, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $1.0M in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. The organization ran a surplus of $217K, a strong 21% operating margin.

Mission

RAISING AWARENESS AND FUNDS FOR NEW GLOBAL, CUTTING-EDGE RESEARCH TO HELP FIND A CURE FOR GLIOBLASTOMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,085,196

Program Service Revenue $0

Investment Income $3,270

Other Revenue $-63,222

TOTAL REVENUE $1,025,244

Expense Breakdown

Grants Paid $195,000

Salaries & Benefits $246,800

Fundraising Expenses $112,745

Program Expenses $582,422

Other Expenses $365,976

TOTAL EXPENSES $807,776

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,025,244	$832,005	+0.2%
Expenses	$807,776	$480,261	+0.7%
Net Income	$217,468	$351,744	-0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$117,387

Total Directors

$137,387

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AMBER BARBACH	FOUNDER AND EXECUTIVE DIRECTOR	60.00	Officer Director	$105,237	$512	$105,749
ELISSA BARBACH	VICE PRESIDENT	20.00	Officer Director	$11,638	$0	$11,638
KYLIE BARNES	SECRETARY	1.00	Officer Director	$0	$0	$0
MARVIN LEW	DIRECTOR	10.00	Director	$0	$0	$0
KATHERINE SNEDEKER	DIRECTOR	10.00	Director	$20,000	$0	$20,000
YONATAN BARDASH	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,025,244	$807,776	$728,675	$217,468
2023	$832,005	$480,261	$492,941	$351,744
2022	$281,490	$260,309	$134,493	$21,181

GLIOBLASTOMA RESEARCH ORGANIZATION INC